RxDoctor Payments Data

Kelly Cole, DO

Family Medicine · Providence, KYNPI 1588638969

Payments from drug & device makers

$2,523in general payments, 2019–2025

Across 163 payments — averaging $15.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$601
  • Lilly USA, LLC$267
  • AstraZeneca$225
  • Novo Nordisk$140
  • Pfizer$124
  • Amgen$91
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,523100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,523 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$4,678
Medicare patients
169
Services billed
377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate88$78,164
OzempicSemaglutide58$62,157
MounjaroTirzepatide46$51,368
EliquisApixaban51$45,436
LinzessLinaclotide56$36,857
TrulicityDulaglutide24$36,550
AuvelityDextromethorphan Hbr/Bupropion21$24,523
FarxigaDapagliflozin Propanediol29$20,797
TradjentaLinagliptin24$20,178
JanumetSitagliptin Phos/Metformin Hcl33$18,403
Janumet XrSitagliptin Phos/Metformin Hcl12$18,376
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$16,052
Stiolto RespimatTiotropium Br/Olodaterol Hcl24$12,920
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$10,764
OxycontinOxycodone Hcl11$10,320

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet, Janumet Xr$28$114,944133 claims
Lilly USA, LLCMounjaro, Trulicity$267$87,91870 claims
Novo NordiskOzempic$140$62,15758 claims
PfizerEliquis, Premarin$124$49,53066 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$225$41,19161 claims
AbbVieLinzess, Synthroid$601$40,223120 claims
Boehringer IngelheimTradjenta, Stiolto Respimat$90$33,09848 claims
Axsome Therapeutics, Inc.Auvelity$76$24,52321 claims
GSKTrelegy Ellipta, Breo Ellipta$88$16,73327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Providence

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →